androcure versus long protocol

pretreatment by androcure and estradiol versus luteal agonist in IVF cycles

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201503001061298

Enrollment

110

Registered

2015-03-07

Start date

2014-03-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female Infertility

Interventions

long luteal agonist protocol

androcure and estradiol

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: IVF patients from age 20-40years

Exclusion criteria

Exclusion criteria: patients with medical disease that is contraindictes IVF or pregnancy

Design outcomes

Primary

Measure	Time frame
pregnancy rate	—

Secondary

Measure	Time frame
GN dose;ovulation induction and fertilization outcom	—

Countries

Egypt

Contacts

Public ContactMohammed Awad

Cairo university

m_oj_h@yahoo.com+201005034393

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026